CARIS LIFE SCIENCES INC
CAI
Industrials
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Caris Life Sciences develops and markets cancer diagnostic tests, including its Caris Molecular Intelligence platform, which relies on proprietary assays to analyze tumor tissue. The development and validation of such medical diagnostics and pharmaceuticals typically involve animal testing as a required component of the regulatory process.
A 2016 legal claim reinstated by the Ninth Circuit Court of Appeals alleged a pharmaceutical company failed to disclose cancers discovered during animal testing related to Caris Life Sciences. This highlights the company's operational reliance on animal-based research to advance its medical products. While specific scale data is not publicly detailed, this reliance places Caris within the broad category of companies whose business model is contingent on the commercial exploitation of animals for product development and regulatory approval.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.